MedPath

Diet for Colonoscopy Preparation in Diabetic Patients

Phase 3
Completed
Conditions
Colonic Diseases
Diabetes Mellitus
Interventions
Dietary Supplement: Low-residue diet
Dietary Supplement: Usual care
Registration Number
NCT02300779
Lead Sponsor
Parc de Salut Mar
Brief Summary

This trial will compare the efficacy of to 2 different sets of dietary recommendations to be followed before colon cleansing for colonoscopy in diabetic patients.

Detailed Description

Consecutive diabetic patients undergoing an ambulatory colonoscopy at the participating sites will be randomized to follow one of two different sets of dietary recommendations. The experimental group will be asked to start a low-residue diet 4 days before the procedure, during which the therapy for diabetes will be adjusted. The control group will be asked to follow a low-residue diet for 3 days followed by a liquid diet during the day before the procedure, and no adjustments will be made to their usual treatment.

Colon cleansing will be undertaken with polyethylene glycol (4 liters in the usual split administration scheme) in both groups.

Analogic visual scales and standardized questionnaires on various aspects that may influence the degree of satisfaction about the preparation will be answered by the participants and collected before the colonoscopy. The endoscopist, blinded to the preparation method, will grade the adequacy of the preparation. Adverse events will be recorded up to 1 month after the procedure

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Patients scheduled for a diagnostic, screening or follow-up outpatient colonoscopy
  • Diabetes mellitus (being treated with insulin or any oral agent).
Exclusion Criteria
  • Unwillingness to participate.
  • Hospital admission at the time of colonoscopy.
  • Inability to follow instructions
  • Active inflammatory bowel disease
  • Previous colectomy.
  • Incomplete colonoscopies due to technical reasons or contraindication for the procedure as evaluated by the endoscopist

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Low-residue dietLow-residue dietSubjects will follow a low-residue diet for 4 days. Their usual treatment for diabetes will be adjusted to the degree of glycemic control.
Usual careUsual careSubjects will follow a low-residue diet for 3 days (from 4 to 2 days before the procedure) and a liquid diet on the following day (the one before the procedure). No changes in their treatment for diabetes will be made
Primary Outcome Measures
NameTimeMethod
Efficacy of the bowel preparation1 hour after the colonoscopy

Rating of the Boston Bowel Preparation Scale (BBPS) by the endoscopist

Secondary Outcome Measures
NameTimeMethod
Acceptability of the preparation (interference with work, leisure activities or sleep6 hours after finishing bowel preparation

Each participant will rate his/her experience in a questionnaire.

Predictors of inadequate bowel preparationBaseline

Independent predictors will be identified by multivariate analysis

Polyp and adenoma detection1 hour after the colonoscopy

Ratio of polyps and adenomas detected in each study arm

Adverse events30 days after the colonoscopy

Description of all spontaneously reported adverse events.

Cecal intubation1 hour after the colonoscopy

Ratio of successful cecal intubations in each study arm

Abdominal pain, nausea, hunger and bloating6 hours after finishing bowel preparation

Each participant will rate his/her experience in an analogue visual scale

Adherence to the planned bowel cleansing method (questionnaire)6 hours after finishing bowel preparation

Each participant will rate his/her experience in a questionnaire.

Symptomatic hypoglycemia6 hours after finishing bowel preparation

Each participant will report his/her experience in a questionnaire

Trial Locations

Locations (2)

Hospital Germans Trias i Pujol

馃嚜馃嚫

Badalona, Barcelona, Spain

Hospital del Mar

馃嚜馃嚫

Barcelona, Spain

漏 Copyright 2025. All Rights Reserved by MedPath